Lifeward Ltd., a global leader in medical technology, has announced the pricing of a $2.6 million public offering. The company will issue 4,000,000 ordinary shares along with warrants to purchase an additional 4,000,000 shares, each priced at $0.65. The warrants, exercisable immediately, will expire five years from issuance. H.C. Wainwright & Co. is serving as the exclusive placement agent. The proceeds are intended for commercial efforts, working capital, and general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9484325-en) on June 25, 2025, and is solely responsible for the information contained therein.